On August 21, 2026, Warrior Met Coal Inc (HCC) shares rose by 3.3% to a current price of $106.73, reflecting strong momentum over recent weeks. The stock has ex

Insights from the Pabrai Investment Funds 13F Filing for the Second Quarter of 2026Mohnish Pabrai (Trades, Portfolio), the Managing Partner of Pabrai Investment

Warrior Met Coal NYSE: HCC reported sharply higher second-quarter earnings and cash generation as its Blue Creek mine contributed additional sales volumes and lower-cost production, while management raised its full-year sales and production outlook.

Warrior Met Coal, Inc. (HCC) Q2 2026 Earnings Call Transcript

Warrior Met Coal (HCC) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $0.11 per share a year ago.

BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE: HCC) (“Warrior” or the “Company”) today announced results for the second quarter of 2026. Warrior is the leading dedicated U.S.-based producer and exporter of high-quality steelmaking coal for the global steel industry. Warrior reported net income for the second quarter of 2026 of $87.4 million, or $1.65 per diluted share, an increase from net income of $5.6 million, or $0.11 per diluted share, in the second quarter of 2025. Adjust.

Warrior Met Coal (HCC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE:HCC) (“Warrior” or the “Company”) today announced that its board of directors has approved a regular quarterly cash dividend of $0.08 per share to be paid on August 17, 2026, to stockholders of record as of the close of business on August 10, 2026.About WarriorWarrior is a U.S.-based, environmentally, and socially minded supplier to the global steel industry. It is dedicated entirely to mining non-thermal metallurgical (met) coal use.

Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) demonstrated a statistically significan

Fifth Third Bancorp grew its stake in shares of Warrior Met Coal (NYSE: HCC) by 4,036.4% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 12,037 shares of the company's stock after purchasing an additional 11,746 shares during the period. Fifth Third Bancorp's holdings in